Latest NewsSep 25, 2025HiFiBiO Therapeutics to Present Updated Phase 1 Clinical Data of Two Immuno-Oncology Programs at the 2025 Annual Meeting of the European Society for Medical Oncology (ESMO) All Filter By: Year20252024202320222021202020192018201720162015Feb 13, 2019Victa Biotherapeutics Appoints Donald W. Kufe to Board of DirectorsDec 10, 2018HiFiBiO Therapeutics and Vikas Sukhatme Join Forces to Discover and Develop Novel Antibody Treatments for CancerOct 15, 2018HiFiBiO Therapeutics Acquires H-Immune TherapeuticsOct 2, 2018Research Collaboration to Develop Technology for the Treatment of CancerJul 30, 2018HiFiBiO Therapeutics Signs Multi-Target Antibody Discovery Agreement with Takeda< 1 … 12 13 14 15 16 … 18 >
